The visit was organised by Gedeon Richter, a leading manufacturer of innovative therapies for women’s health, and gave the doctors a unique experience and insight into the history and future of IVF.
The visit was organised by Luis Freire, Senior Product Manager at Gedeon Richter, Portugal. One of Richter’s most important niche areas is its Women’s Healthcare division, and the company offers a portfolio of therapies in areas of unmet need such as female fertility, uterine fibroids, and endometriosis.
The company is active in these therapeutic areas, building on a programme of acquisitions of companies (PregLem and Esmya in 2010 and Finox and Bemfola in 2016) and in-licensing of products (Cyclogest from LDC and Ryeqo from Myovant).
Luis Freire and his colleagues facilitated a visit of 20 Portuguese doctors from leading hospitals to Bourn Hall to find out about the story of IVF, how cutting-edge science is increasing understanding of human reproduction, and the future directions and challenges of this field of medicine.
Luis Freire comments: “Bourn Hall is such a symbolic place in the history of IVF; it was fascinating to meet scientists and fertility specialists that had worked with Professor Edwards, a co-pioneer in IVF, and to hear about the current challenges and future developments in reproductive medicine.”
Dr Thanos Papathanasiou, CEO and Medical Director at Bourn Hall, comments: “It was a pleasure to share our journey with Portuguese colleagues and to hear of their experiences. Collaboration has always been vital in reproductive medicine and there is still so much to learn.”
Find out more about Bourn Hall at bournhall.co.uk.
